| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2021 | Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients with Indeterminate Phase | Huang, Daniel Q.; Li, Xiaohe; Le, Michael H.; Le, An K.; Yeo, Yee Hui; Trinh, Huy N.; Zhang, Jian; Li, Jiayi; Wong, Christopher; Wong, Clifford; Cheung, Ramsey C.; Yang, Hwai-I ; Nguyen, Mindie H. | Clinical Gastroenterology and Hepatology | | | |
| 2019 | On Identification of Agonistic Interaction: Hepatitis B and C Interaction on Hepatocellular Carcinoma | SH Lin; YT Huang ; HI Yang | STATISTICS IN MEDICINE 38(13), 2467-2476 | | | |
| 2020 | Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer | Liu, Zhiwei; Derkach, Andriy; Yu, Kelly J.; Yeager, Meredith; Chang, Yu-Sun; Chen, Chien-Jen; Gyllensten, Ulf; Lan, Qing; Lee, Mei-Hsuan; McKay, James D.; Rothman, Nathaniel; Yang, Hwai-I ; Hildesheim, Allan; Pfeiffer, Ruth M. | Cancer Research 81(4), 1148-1152 | | | |
| 2016 | Performance Metrics for Selecting Single Nucleotide Polymorphisms in Late-onset Alzheimer’s Disease | Chen, YC; Hsiao, CJ; Jung, CC; Hu, HH; Chen, JH; Lee, WC; Chiou, JM; Chen, TF; Sun, Y; Wen, LL; Yip, PK; Chu, YM; Chen, CJ ; Yang, HI | Scientific reports 6, 36155 | | | |
| 2024 | Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients | Lin, HC; Jeng, WJ; Liu, J; Pan, MH; Lee, MH; Batrla-Utermann, R; Lu, SN; Chen, CF; Yang, HI ; Chen, CJ | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 59(8), 993-1002 | | | |
| 2020 | Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies | Petrick, JL; Florio, AA; Koshiol, J; Pfeiffer, RM; Yang, B; Yu, K; Chen, CJ ; Yang, HI ; Lee, MH; McGlynn, KA | International journal of cancer 147(10), 2743-2753 | | | |
| 2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park, J; Le, AK; Tseng, TC; Yeh, ML; Jun, DW; Trinh, H; Wong, GLH; Chen, CH; Peng, CY; Kim, SE; Oh, H; Kwak, MS; Cheung, KS; Toyoda, H; Hsu, YC; Jeong, JY; Yoon, EL; Ungtrakul, T; Zhang, J; Xie, Q; Ahn, SB; Enomoto, M; Shim, JJ; Cunningham, C; Jeong, SW; Cho, YK; Ogawa, E; Huang, R; Lee, DH; Takahashi, H; Tsai, PC; Huang, CF; Dai, CY; Tseng, CH; Yasuda, S; Kozuka, R; Li, J; Wong, C; Wong, CC; Zhao, C; Hoang, J; Eguchi, Y; Wu, C; Tanaka, Y; Gane, E; Tanwandee, T; Cheung, R; Yuen, MF; Lee, HS; Yu, ML; Kao, JH; Yang, HI ; Nguyen, MH | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20(4), 874-885.e4 | | | |
| 2023 | Rapid decline rather than absolute level of HBsAg predicts its seroclearance in untreated chronic hepatitis B patients from Taiwanese communities | Lin, HC; Liu, J; Pan, MH; Lee, MH; Batrla-Utermann, R; Lu, SN; Jeng, WJ; Yang, HI ; Chen, CJ | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 14(8), e00586 | | | |
| 2020 | Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. | Yang, HI ; Yeh, ML; Wong, GL; Peng, CY; Chen, CH; Trinh, HN; Cheung, KS; Xie, Q; Su, TH; Kozuka, R; Lee, DH; Ogawa, E; Zhao, C; Ning, HB; Huang, R; Li, J; Zhang, JQ; Ide, T; Xing, H; Iwane, S; Takahashi, H; Wong, C; Wong, C; Lin, CH; Hoang, J; le, A; Henry, L; Toyoda, H; Ueno, Y; Gane, EJ; Eguchi, Y; Kurosaki, M; Wu, C; Liu, C; Shang, J; Furusyo, N; Enomoto, M; Kao, JH; Yuen, MF; Yu, ML; Nguyen, MH | The Journal of infectious diseases 221(3), 389-399 | | | |
| 2016 | Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B | Poh, Z; Shen, L; Yang, HI ; Seto, WK; Wong, VW; Lin, CY; Goh, BG; Chang, PJ; Chan, HL; Yuen, MF; Chen, CJ ; Tan, CK | GUT 65(5), 887-894 | | | |
| 2019 | Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study | Nguyen, MH; Yang, HI ; Le, A; Henry, L; Nguyen, N; Lee, MH; Zhang, J; Wong, C; Wong, C; Trinh, H | The Journal of infectious diseases 219(1), 10-18 | | | |
| 2016 | Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. | Yang, HI ; Nguyen, N; Hoang, J; Kim, Y; Vu, V; Le, A; Chaung, K; Nguyen, V; Trinh, H; Li, J; Zhang, J; Hsing, A; Chen, CJ ; Nguyen, MH | Alimentary pharmacology & therapeutics 44(8), 846-855 | | | |
| 2021 | Reproductive and environmental exposures and the breast cancer risk in Taiwanese women | Wu, HC; Yang, HI ; Lin, PH; Chen, CJ ; Santella, RM; Terry, MB | Scientific reports 11(1), 15656 | | | |
| 2016 | Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis | Chien, J; Liu, J; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Yang, HI ; Chen, CJ | Journal of gastroenterology and hepatology 31(12), 1971-1977 | | | |
| 2023 | Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review | Hsu, CC; Gopalakrishna, H; Mironova, M; Lee, MH; Chen, CJ ; Yang, HI ; Wiese, M; Chang, KM; Wright, EC; Abijo, T; Feld, JJ; Kaplan, DE | CLINICAL INFECTIOUS DISEASES 77(Suppl 3), S245-S256 | | | |
| 2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, W; Chang, TT; Yang, HI ; Peng, CY; Su, CW; Su, TH; Hu, TH; Yu, ML; Yang, HC; Wu, JC | Hepatology international 15, 1421-1430 | | | |
| 2023 | Serum HBcrAg and hepatocellular carcinoma in a Taiwanese population seronegative for HBsAg and anti-HCV | Hsieh, YC; Pan, MH; Jeng, WJ; Hu, HH; Liu, J; Mizokami, M; Chen, CJ ; Yang, HI | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 21(5), 1303-1313 | | | |
| 2016 | Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression. | Liu, J; Yang, HI ; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Chen, CJ | HEPATOLOGY 64(2), 381-389 | | | |
| 2022 | Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B | Hu, HH; Jeng, WJ; Pan, MH; Luo, WS; Chang, CL; Huang, YT ; Su, CY; Chiang, CT; Jen, CL; Chien, YC; Lu, SN; Wang, LY; Huang, LR; Lee, MH; Liu, J; Nguyen, MH; Chen, CJ ; Yang, HI | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 55(5), 558-567 | | | |
| 2022 | Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B | Chu, YJ; Jeng, WJ; Pan, MH; Hu, HH; Luo, WS; Su, CY; Chiang, CT; Jen, CL; Chen, CJ ; Yang, HI | Journal of Gastroenterology 57, 423-432 | | | |
